You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 4,695,590


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,695,590
Title: Method for retarding aging
Abstract:Methods and compositions are provided for retarding aging, i.e., inhibiting damage to human cells caused by toxic byproducts of oxygen metabolism. The anti-aging active ingredient is a compound or mixture of compounds represented by the following structural formula: ##STR1## wherein m is 0, 1 or 2; n is 0 or 1; R1 is hydrogen, halogen or hydroxy; and R2 and R3 each independently represent hydrogen or methyl provided that when m is 0, n is 0 and when m is 1 or 2, n is 1 and R1 is hydroxy or halogen and that when m is 2, each R2 can be the same or different and each R3 can be the same or different or a pharmaceutically acceptable alkali or alkaline earth metal salt thereof.
Inventor(s): Lippman; Richard D. (Scottsdale, AZ)
Assignee: California Health Technologies (Los Angeles, CA)
Application Number:06/859,464
Patent Claim Types:
see list of patent claims
Use; Composition; Delivery; Compound; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 4,695,590: A Comprehensive Analysis

Introduction

When analyzing a patent, it is crucial to delve into its scope, claims, and the broader patent landscape to fully comprehend its significance and implications. This article will provide a detailed analysis of United States Patent 4,695,590, focusing on its claims, the criteria for patentability, and the relevant legal and policy frameworks.

Patent Basics: Understanding the USPTO and Patent Types

The U.S. Patent and Trademark Office (USPTO) is the agency responsible for granting U.S. patents and registering trademarks. The USPTO grants three main types of patents: utility patents, design patents, and plant patents. Utility patents, which are the most common, are granted for new and useful processes, machines, articles of manufacture, or compositions of matter, or any new and useful improvement thereof[4].

Patentability Requirements

For an invention to be patentable, it must meet several criteria:

  • Usefulness: The invention must be operable and provide some tangible benefit.
  • Novelty: The invention must not be fully anticipated by prior art.
  • Nonobviousness: The invention must not have been readily within the ordinary skills of a competent artisan at the time it was made[4].

Analyzing Patent Claims

Patent claims define the scope of the invention and are critical in determining patentability. Two key metrics for measuring patent scope are independent claim length and independent claim count. These metrics can indicate the breadth and clarity of the patent claims, which are important factors in patent quality debates[3].

Independent Claim Length and Count

Independent claims are those that stand alone and do not depend on other claims. The length and count of these claims can provide insights into the patent's scope. Generally, narrower claims with shorter lengths and lower counts are associated with a higher probability of grant and a shorter examination process[3].

United States Patent 4,695,590: Specific Analysis

Patent Overview

To analyze the scope and claims of U.S. Patent 4,695,590, one must first understand the invention it covers. This involves reviewing the patent's abstract, description, and claims.

Claims Structure

The claims section of the patent is where the inventor defines the boundaries of the invention. Here, you would look for:

  • Independent Claims: These claims define the core aspects of the invention.
  • Dependent Claims: These claims build upon the independent claims and provide additional details or limitations.

Claim Language and Scope

The language used in the claims is crucial. Clear and specific language helps in defining the scope of the patent and avoids ambiguity. Broader claims may face more scrutiny during the examination process due to potential overlaps with prior art[3].

Obviousness-Type Double Patenting (ODP)

ODP is a doctrine that prevents the granting of multiple patents for the same invention or obvious variations thereof. This is particularly relevant when dealing with continuation-in-part patents or patents with overlapping claims. The case of In re Cellect LLC highlights the complexities of ODP, where multiple patents in a family were invalidated due to ODP, tracing back to a single family member patent that did not receive a Patent Term Adjustment (PTA)[1].

Patent Term Adjustments and Extensions

Patent Term Adjustments (PTA) and Extensions (PTE) can affect the lifespan of a patent. PTA is granted for delays during the prosecution process, while PTE is granted under specific conditions such as regulatory review. These adjustments can impact the patent's expiration date and its validity under ODP analysis[1].

Legal and Policy Frameworks

The USPTO operates under a framework defined by statutory laws, judicial interpretations, and administrative guidelines. For instance, the Novartis AG v. Ezra Ventures LLC case clarified that ODP does not invalidate a validly obtained Patent Term Extension under 35 U.S.C. ยง 156[1].

Small Claims Patent Court Considerations

The concept of a small claims patent court has been explored to address issues related to patent litigation costs and accessibility. Such a court could potentially simplify the process for resolving patent disputes, especially for smaller entities. However, it involves complex legal, policy, and practical considerations, as highlighted in the Administrative Conference of the United States (ACUS) study[5].

Impact on Innovation and Litigation

The scope and claims of a patent can significantly impact innovation and litigation. Broad or overly complex claims can lead to increased licensing and litigation costs, potentially discouraging innovation. Conversely, well-defined and narrow claims can provide clear boundaries, reducing the risk of disputes and fostering a more innovative environment[3].

Key Takeaways

  • Patent Claims: The claims section is critical in defining the scope of the invention.
  • Patentability Criteria: Inventions must be useful, novel, and nonobvious to be patentable.
  • ODP: Prevents the granting of multiple patents for the same invention or obvious variations.
  • PTA and PTE: Adjustments and extensions can impact the patent's lifespan and validity.
  • Legal Frameworks: Statutory laws, judicial interpretations, and administrative guidelines govern patent practices.
  • Innovation and Litigation: Clear and narrow claims can promote innovation and reduce litigation risks.

FAQs

What are the main types of patents granted by the USPTO?

The USPTO grants utility patents, design patents, and plant patents[4].

How do independent claim length and count affect patent scope?

Narrower claims with shorter lengths and lower counts are associated with a higher probability of grant and a shorter examination process[3].

What is Obviousness-Type Double Patenting (ODP)?

ODP prevents the granting of multiple patents for the same invention or obvious variations thereof[1].

How do Patent Term Adjustments (PTA) and Extensions (PTE) impact a patent?

PTA and PTE can extend the lifespan of a patent due to delays during prosecution or regulatory review, affecting its expiration date and validity under ODP analysis[1].

Why is the concept of a small claims patent court being explored?

The concept is being explored to simplify the process for resolving patent disputes, especially for smaller entities, and to address issues related to patent litigation costs and accessibility[5].

Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. U.S. Patent and Trademark Office (USPTO), USAGov.
  3. Patent Claims and Patent Scope, SSRN, September 29, 2016.
  4. Patents and Innovation Policy, Congressional Research Service, August 2, 2022.
  5. U.S. Patent Small Claims Court, Administrative Conference of the United States.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,695,590

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 4,695,590

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 87473 ⤷  Subscribe
Australia 645771 ⤷  Subscribe
Australia 6930591 ⤷  Subscribe
Australia 7484887 ⤷  Subscribe
Canada 1305669 ⤷  Subscribe
Germany 3785136 ⤷  Subscribe
European Patent Office 0265514 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.